CoChat
Sign Up
Cited by 50

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Enhancement of BACE1 Activity by p25/Cdk5-Mediated Phosphorylation in Alzheimer’s Disease

Song, Woo-Joo, Son, Mi-Young, Lee, Hye-Won, Seo, Hyemyung, Kim, Jeong Hee, Chung, Sul-Hee·2015·PLOS ONE
DOI 10.1371/journal.pone.0136950PMC PMC4552876
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0136950

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • BACE1 is phosphorylated, with phosphorylation at threonine 252 via p25/Cdk5 pathways found to stimulate protease activity.

    “BACE1 is also phosphorylated, with phosphorylation at threonine 252 via p25/Cdk5 pathways found to stimulate protease activity.”

    From BACE1: More than just a β‐secretase (2022) · cites this paper as [78]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 55

  1. R Vassar, 1999, Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE, Science, 286, 735, 10.1126/science.286.5440.735 · DOI · Paper page
  2. J Apelt, 2004, Aging-related increase in oxidative stress correlates with developmental pattern of beta-secretase activity and beta-amyloid plaque formation in transgenic Tg2576 mice with Alzheimer-like pathology, Int J Dev Neurosci, 22, 475, 10.1016/j.ijdevneu.2004.07.006 · DOI
  3. H Fukumoto, 2002, Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease, Arch Neurol, 59, 1381, 10.1001/archneur.59.9.1381 · DOI · Paper page
  4. RM Holsinger, 2002, Increased expression of the amyloid precursor beta-secretase in Alzheimer's disease, Ann Neurol, 51, 783, 10.1002/ana.10208 · DOI · Paper page
  5. KR Sadleir, 2012, Cdk5 protein inhibition and Abeta42 increase BACE1 protein level in primary neurons by a post-transcriptional mechanism: implications of CDK5 as a therapeutic target for Alzheimer disease, J Biol Chem, 287, 7224, 10.1074/jbc.M111.333914 · DOI
  6. LB Yang, 2003, Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease, Nat Med, 9, 3, 10.1038/nm0103-3 · DOI · Paper page
  7. H Harada, 2006, Beta-site APP cleaving enzyme 1 (BACE1) is increased in remaining neurons in Alzheimer's disease brains, Neurosci Res, 54, 24, 10.1016/j.neures.2005.10.001 · DOI
  8. JH Stockley, 2006, Altered beta-secretase enzyme kinetics and levels of both BACE1 and BACE2 in the Alzheimer's disease brain, FEBS Lett, 580, 6550, 10.1016/j.febslet.2006.10.076 · DOI
  9. G Leuba, 2005, Neuronal and nonneuronal quantitative BACE immunocytochemical expression in the entorhinohippocampal and frontal regions in Alzheimer's disease, Dement Geriatr Cogn Disord, 19, 171, 10.1159/000083496 · DOI
  10. SS Hebert, 2008, Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression, Proc Natl Acad Sci U S A, 105, 6415, 10.1073/pnas.0710263105 · DOI · Paper page
  11. K Yasojima, 2001, Relationship between beta amyloid peptide generating molecules and neprilysin in Alzheimer disease and normal brain, Brain Res, 919, 115, 10.1016/S0006-8993(01)03008-6 · DOI
  12. P Preece, 2003, Beta-secretase (BACE) and GSK-3 mRNA levels in Alzheimer's disease, Brain Res Mol Brain Res, 116, 155, 10.1016/S0169-328X(03)00233-X · DOI
  13. JH Stockley, 2008, Understanding BACE1: essential protease for amyloid-beta production in Alzheimer's disease, Cell Mol Life Sci, 65, 3265, 10.1007/s00018-008-8271-3 · DOI
  14. R Dhavan, 2001, A decade of CDK5, Nat Rev Mol Cell Biol, 2, 749, 10.1038/35096019 · DOI
  15. GN Patrick, 1999, Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration, Nature, 402, 615, 10.1038/45159 · DOI
  16. JE Swatton, 2004, Increased MAP kinase activity in Alzheimer's and Down syndrome but not in schizophrenia human brain, Eur J Neurosci, 19, 2711, 10.1111/j.0953-816X.2004.03365.x · DOI
  17. A Tandon, 2003, Brain levels of CDK5 activator p25 are not increased in Alzheimer's or other neurodegenerative diseases with neurofibrillary tangles, J Neurochem, 86, 572, 10.1046/j.1471-4159.2003.01865.x · DOI
  18. Y Wen, 2008, Transcriptional regulation of beta-secretase by p25/cdk5 leads to enhanced amyloidogenic processing, Neuron, 57, 680, 10.1016/j.neuron.2008.02.024 · DOI
  19. MY Son, 2010, Expression of p25, an aberrant cyclin-dependent kinase 5 activator, stimulates basal secretion in PC12 cells, Mol Cells, 29, 51, 10.1007/s10059-010-0016-0 · DOI
  20. SH Chung, 1995, Evidence that the Rab3a-binding protein, rabphilin3a, enhances regulated secretion. Studies in adrenal chromaffin cells, J Biol Chem, 270, 16714, 10.1074/jbc.270.28.16714 · DOI
  21. MK Ahlijanian, 2000, Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5, Proc Natl Acad Sci U S A, 97, 2910, 10.1073/pnas.040577797 · DOI
  22. H Seo, 2004, Generalized brain and skin proteasome inhibition in Huntington's disease, Ann Neurol, 56, 319, 10.1002/ana.20207 · DOI · Paper page
  23. JH Park, 2012, Phosphorylation of Munc18-1 by Dyrk1A regulates its interaction with Syntaxin 1 and X11alpha, J Neurochem, 122, 1081, 10.1111/j.1471-4159.2012.07861.x · DOI
  24. SR Ryoo, 2007, DYRK1A-mediated hyperphosphorylation of Tau. A functional link between Down syndrome and Alzheimer disease, J Biol Chem, 282, 34850, 10.1074/jbc.M707358200 · DOI
  25. MS Lee, 2003, APP processing is regulated by cytoplasmic phosphorylation, J Cell Biol, 163, 83, 10.1083/jcb.200301115 · DOI
  26. P Lin, 1998, The mammalian calcium-binding protein, nucleobindin (CALNUC), is a Golgi resident protein, J Cell Biol, 141, 1515, 10.1083/jcb.141.7.1515 · DOI
  27. SY Lee, 2004, Regulation of synaptojanin 1 by cyclin-dependent kinase 5 at synapses, Proc Natl Acad Sci U S A, 101, 546, 10.1073/pnas.0307813100 · DOI
  28. A Schmechel, 2004, Human BACE forms dimers and colocalizes with APP, J Biol Chem, 279, 39710, 10.1074/jbc.M402785200 · DOI
  29. C Sidera, 2002, Pro-domain removal in ASP-2 and the cleavage of the amyloid precursor are influenced by pH, BMC Biochem, 3, 25, 10.1186/1471-2091-3-25 · DOI
  30. L Marlow, 2003, Beta-secretase processing of the Alzheimer's amyloid protein precursor (APP), J Mol Neurosci, 20, 233, 10.1385/JMN:20:3:233 · DOI
  31. K Iijima, 2000, Neuron-specific phosphorylation of Alzheimer's beta-amyloid precursor protein by cyclin-dependent kinase 5, J Neurochem, 75, 1085, 10.1046/j.1471-4159.2000.0751085.x · DOI
  32. GG Westmeyer, 2004, Dimerization of BACE, J Biol Chem, 279, 53205
  33. L Hong, 2000, Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor, Science, 290, 150, 10.1126/science.290.5489.150 · DOI
  34. HW Lee, 2007, Overexpression of BACE1 stimulates spontaneous basal secretion in PC12 cells, Neurosci Lett, 421, 178, 10.1016/j.neulet.2007.01.082 · DOI
  35. JT Huse, 2000, Maturation and endosomal targeting of beta-site amyloid precursor protein-cleaving enzyme. The Alzheimer's disease beta-secretase, J Biol Chem, 275, 33729, 10.1074/jbc.M004175200 · DOI · Paper page
  36. X Sun, 2012, Regulation of beta-site APP-cleaving enzyme 1 gene expression and its role in Alzheimer's disease, J Neurochem, 120, 62, 10.1111/j.1471-4159.2011.07515.x · DOI
  37. R Sultana, 2007, Regional expression of key cell cycle proteins in brain from subjects with amnestic mild cognitive impairment, Neurochem Res, 32, 655, 10.1007/s11064-006-9123-x · DOI
  38. P Giusti-Rodriguez, 2011, Synaptic deficits are rescued in the p25/Cdk5 model of neurodegeneration by the reduction of beta-secretase (BACE1), J Neurosci, 31, 15751, 10.1523/JNEUROSCI.3588-11.2011 · DOI
  39. AD Snow, 1990, Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome, Am J Pathol, 137, 1253
  40. G Perry, 1991, Association of heparan sulfate proteoglycan with the neurofibrillary tangles of Alzheimer's disease, J Neurosci, 11, 3679, 10.1523/JNEUROSCI.11-11-03679.1991 · DOI
  41. AM Cataldo, 2000, Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations, Am J Pathol, 157, 277, 10.1016/S0002-9440(10)64538-5 · DOI · Paper page
  42. AM Cataldo, 2004, Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome, Neurobiol Aging, 25, 1263, 10.1016/j.neurobiolaging.2004.02.027 · DOI · Paper page
  43. CM Fader, 2009, Autophagy and multivesicular bodies: two closely related partners, Cell Death Differ, 16, 70, 10.1038/cdd.2008.168 · DOI
  44. WH Yu, 2005, Macroautophagy—a novel Beta-amyloid peptide-generating pathway activated in Alzheimer's disease, J Cell Biol, 171, 87, 10.1083/jcb.200505082 · DOI · Paper page
  45. RA Nixon, 2005, Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study, J Neuropathol Exp Neurol, 64, 113, 10.1093/jnen/64.2.113 · DOI · Paper page
  46. RA Nixon, 2011, Autophagy failure in Alzheimer's disease—locating the primary defect, Neurobiol Dis, 43, 38, 10.1016/j.nbd.2011.01.021 · DOI · Paper page
  47. K Ditaranto, 2001, Lysosomal membrane damage in soluble Abeta-mediated cell death in Alzheimer's disease, Neurobiol Dis, 8, 19, 10.1006/nbdi.2000.0364 · DOI
  48. AJ Yang, 1998, Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Abeta1-42 pathogenesis, J Neurosci Res, 52, 691, 10.1002/(SICI)1097-4547(19980615)52:6<691::AID-JNR8>3.0.CO;2-3 · DOI
  49. VF Taelman, 2010, Wnt signaling requires sequestration of glycogen synthase kinase 3 inside multivesicular endosomes, Cell, 143, 1136, 10.1016/j.cell.2010.11.034 · DOI · Paper page
  50. RH Takahashi, 2002, Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology, Am J Pathol, 161, 1869, 10.1016/S0002-9440(10)64463-X · DOI · Paper page
  51. PA Lochhead, 2005, Activation-loop autophosphorylation is mediated by a novel transitional intermediate form of DYRKs, Cell, 121, 925, 10.1016/j.cell.2005.03.034 · DOI
  52. L Liu, 2013, Palmitate-activated astrocytes via serine palmitoyltransferase increase BACE1 in primary neurons by sphingomyelinases, Neurobiol Aging, 34, 540, 10.1016/j.neurobiolaging.2012.05.017 · DOI
  53. W Noble, 2003, Cdk5 is a key factor in tau aggregation and tangle formation in vivo, Neuron, 38, 555, 10.1016/S0896-6273(03)00259-9 · DOI
  54. JC Cruz, 2003, Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles, Neuron, 40, 471, 10.1016/S0896-6273(03)00627-5 · DOI · Paper page
  55. JC Cruz, 2006, p25/cyclin-dependent kinase 5 induces production and intraneuronal accumulation of amyloid beta in vivo, J Neurosci, 26, 10536, 10.1523/JNEUROSCI.3133-06.2006 · DOI

Cited by

Sorted by citations

Metadata

Authors
Song, W.-J., Son, M.-Y., Lee, H.-W., Seo, H., Kim, J. H., & Chung, S.-H.
Venue
PLOS ONE
Publisher
Public Library of Science (PLoS)
Published
2015-08-28
Volume
10
Issue
8
Pages
e0136950
ISSN
1932-6203
DOI
10.1371/journal.pone.0136950
PMC
PMC4552876
Cited by
50
References
5
Language
en
Licence
creativecommons.org/licenses/by/4.0/ (vor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review